Search results for "Venous thromboembolism"
Wells score, negative D-dimer test can rule out pulmonary embolism in primary care
A Wells score of 4 or lower and a negative qualitative D-dimer test result can safely and efficiently exclude pulmonary embolism in primary care, a study found.
https://immattersacp.org/weekly/archives/2012/10/16/5.htm
16 Oct 2012
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://immattersacp.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021
Low-molecular-weight heparin may not prevent VTE after knee arthroscopy or lower-leg casting, studies find
The Prevention of Thrombosis after Knee Arthroscopy (POT-KAST) and the Prevention of Thrombosis after Lower Leg Plaster Cast (POT-CAST) trials used the same methods and design to compare a prophylactic dose of low-molecular-weight heparin or no anticoagulant therapy.
https://immattersacp.org/weekly/archives/2016/12/13/4.htm
13 Dec 2016
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a new trial, tocilizumab had mixed results, and remdesivir got full approval, among other COVID-19 news.
https://immattersacp.org/weekly/archives/2020/10/27/1.htm
27 Oct 2020
IDSA issues new clinical practice guideline for outpatient parenteral antimicrobial therapy
The new guideline updates 2004 recommendations from the Infectious Diseases Society of America (IDSA) with evidence from recent research, particularly on the safety of outpatient parenteral therapy.
https://immattersacp.org/weekly/archives/2018/11/20/5.htm
20 Nov 2018
Fixed-dose oral rivaroxaban appears noninferior to standard therapy for PE
Fixed-dose oral rivaroxaban is as effective as standard anticoagulant therapy for pulmonary embolism (PE) and may have a lower bleeding risk, a new study found.
https://immattersacp.org/weekly/archives/2012/03/27/5.htm
27 Mar 2012
IDSA offers criteria on testing for COVID-19; new research looks at clots, treatments
The Infectious Diseases Society of America (IDSA) released guidance for COVID-19 testing among inpatients and outpatients, while studies offered further support for anticoagulation but showed no benefit from hydroxychloroquine or lopinavir-ritonavir.
https://immattersacp.org/weekly/archives/2020/05/12/1.htm
12 May 2020
Web-based decision support tool may help determine safety of outpatient PE management
The tool was added to the patient care workflow in the ED after the diagnosis of pulmonary embolism (PE) was confirmed but before site-of-care decision making was completed.
https://immattersacp.org/weekly/archives/2018/11/13/4.htm
13 Nov 2018
Use of hormonal contraceptive pills may be associated with increased risk of breast cancer
While the 20% increased risk among women using contemporary formulations of oral contraceptives is similar to that initially reported among users of older formulations, an editorial noted, the finding that breast cancer risk continues to be elevated for five years or more should be regarded as preliminary because the increase in risk would not have remained significant after adjustment.
https://immattersacp.org/weekly/archives/2017/12/12/4.htm
12 Dec 2017
MKSAP Quiz: 10-year history of hot flushes
A 61-year-old woman is evaluated for hot flushes, which have been persistent for the last 10 years. They occur at least 7 times per day, last for approximately 60 seconds, and are associated with severe sweating, palpitations, and occasional nausea. She is awakened several times per night. Following a review of medicines and herbal supplements, taking her medical history, and a physical exam, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2013/11/05/3.htm
5 Nov 2013